JC
Therapeutic Areas
Island Pharmaceuticals Pipeline
| Drug | Indication | Phase |
|---|---|---|
| ISLA-101 | Dengue fever and Zika virus infection | Phase 2a/b Challenge |
| Galidesivir | Broad‑spectrum antiviral for RNA viruses (e.g., Ebola, Zika, Marburg) | Clinical stage (potential acquisition) |